We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+15.2%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.07B
AUM Growth
+$251M
Cap. Flow
-$68.7M
Cap. Flow %
-3.32%
Top 10 Hldgs %
44.01%
Holding
2,647
New
722
Increased
455
Reduced
467
Closed
877

Sector Composition

Rank Sector Weight
1 Technology 6.57%
2 Consumer Discretionary 4.71%
3 Industrials 3.64%
4 Healthcare 3.58%
5 Communication Services 3.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VICI icon
751
VICI Properties
VICI
$28.7B
$158K 0.01%
6,762
+3,633
+116% +$81.6K
STOR
752
DELISTED
STORE Capital Corporation
STOR
$158K 0.01%
5,744
+3,639
+173% +$92.4K
SIOX
753
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$157K 0.01%
34,000
+16,100
+90% +$53.1K
LNT icon
754
Alliant Energy
LNT
$17.7B
$156K 0.01%
+3,028
New +$158K
SCO icon
755
CALL
ProShares UltraShort Bloomberg Crude Oil
SCO
$598M
$156K 0.01%
99
+93
+1,550% +$122K
SEDG icon
756
SolarEdge
SEDG
$1.98B
$156K 0.01%
+656
New +$126K
EPC icon
757
Edgewell Personal Care
EPC
$1.29B
$155K 0.01%
5,568
+1,215
+28% +$36K
LMNX
758
DELISTED
Luminex Corp
LMNX
$154K 0.01%
5,865
+4,998
+576% +$153K
TLK icon
759
Telkom Indonesia
TLK
$14.7B
$153K 0.01%
+8,800
New +$176K
TOL icon
760
Toll Brothers
TOL
$14B
$152K 0.01%
3,117
-9,151
-75% -$370K
TWNK
761
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$152K 0.01%
+12,365
New +$155K
VERX icon
762
Vertex
VERX
$1.97B
$149K 0.01%
+6,498
New +$158K
NFH
763
DELISTED
New Frontier Health Corporation Ordinary Shares
NFH
$149K 0.01%
+19,470
New +$160K
AGO icon
764
Assured Guaranty
AGO
$3.34B
$148K 0.01%
6,894
+492
+8% +$10.8K
NBIX icon
765
Neurocrine Biosciences
NBIX
$16.8B
$148K 0.01%
1,538
+1,473
+2,266% +$170K
KBE icon
766
CALL
State Street SPDR S&P Bank ETF
KBE
$1.71B
$147K 0.01%
5,000
UVV icon
767
Universal Corp
UVV
$1.18B
$147K 0.01%
+3,504
New +$150K
XNCR icon
768
Xencor
XNCR
$1.6B
$147K 0.01%
3,800
+2,693
+243% +$93.6K
HZO icon
769
MarineMax
HZO
$1.15B
$146K 0.01%
5,683
+5,645
+14,855% +$155K
SPOT icon
770
CALL
Spotify
SPOT
$105B
$146K 0.01%
600
-100
-14% -$25.8K
XBI icon
771
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$145K 0.01%
1,300
-2,300
-64% -$258K
SON icon
772
Sonoco
SON
$5.72B
$144K 0.01%
2,810
-1,702
-38% -$90.1K
SEI
773
Solaris Energy Infrastructure
SEI
$3.86B
$144K 0.01%
+22,774
New +$167K
CUBE icon
774
CubeSmart
CUBE
$9.23B
$143K 0.01%
4,423
-533
-11% -$16.1K
ARNA
775
DELISTED
Arena Pharmaceuticals Inc
ARNA
$143K 0.01%
1,914
+157
+9% +$10.5K

Similar funds

Prelude Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Prelude Capital Management held 2,647 positions worth $2.07B, up 14% from $1.82B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Prelude Capital Management withdrew a net $68.7M in Q3 2020, closing 877 positions and reducing 467 holdings. Its most notable exit was Invesco QQQ Trust, an estimated $9.18M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6.6% of assets, down from 7% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Prelude Capital Management opened a new position in Equitrans Midstream Corporation Common Stock worth $14.9M.

  • Prelude Capital Management's largest Q3 2020 buy was Equitrans Midstream Corporation Common Stock: 1,760,179 shares worth $14.9M.
  • Prelude Capital Management added most to Alibaba in Q3 2020, an estimated $12.1M increase.
  • Prelude Capital Management's biggest Q3 2020 reduction was Broadcom, cutting an estimated $5.72M.
  • Prelude Capital Management fully exited Invesco QQQ Trust in Q3 2020, selling an estimated $9.18M.
  • Prelude Capital Management's ten largest holdings make up 44% of its $2.07B portfolio in Q3 2020.
  • Prelude Capital Management opened 722 new positions and closed 877 in Q3 2020.
  • Prelude Capital Management's portfolio value rose 14% quarter-over-quarter to $2.07B.

Based on Prelude Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.